Regeneron Pharmaceuticals Inc (REGN)

766.39 +5.15 (+0.68%) USD  |  NASDAQ  |  Dec 02, 16:00
765.00 -1.39 (-0.18%) Pre-Market: 08:59
More

Regeneron Pharmaceuticals News

News

Headline
Wire
Time (ET)
Can These 2 Stocks Crush the Market Again in 2023?
Yahoo
12/04 09:37
Regeneron Pharmaceuticals' (NASDAQ:REGN) three-year earnings growth trails the stellar shareholder returns
Yahoo
12/04 07:01
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
12/02 16:13
Regeneron's (REGN) sBLA for Evkeeza Gets FDA Priority Review
Yahoo
12/01 08:46
Regeneron ESMO IO Presentations Highlight Potential of Fianlimab and Libtayo® (cemiplimab) in Multiple Solid Tumor Types
PR Newswire
12/01 07:00
Regeneron Pharmaceuticals' Evkeeza Accepted by US FDA for Priority Review
MT Newswires
11/30 13:12
Regeneron's Evkeeza Under FDA Priority Review For Younger Kids With Inherited Form Of High Cholesterol
Yahoo
11/30 10:51
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
Yahoo
11/30 09:06
Evkeeza® (evinacumab-dgnb) sBLA for Children with Ultra-rare Inherited Form of High Cholesterol Accepted for FDA Priority Review
PR Newswire
11/30 08:05
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Price Is Out Of Tune With Earnings
Yahoo
11/30 07:00
2 Market-Beating Stocks That Can Continue Rising in 2023
Yahoo
11/30 05:35
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
11/28 04:44
Dexcom Leads 5 Stocks Near Buy Points
Yahoo
11/26 07:00
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders sold US$7.0m worth of stock suggesting impending weakness.
Yahoo
11/26 06:00
Regeneron (REGN) Outperforms YTD: What's in Store for 2023?
Yahoo
11/25 09:13
Biotech Stock Roundup: CTMX Surges on REGN's Deal, APLS Up on Regulatory Update
Yahoo
11/23 12:18
Regeneron's (REGN) Libtayo Gets EC Nod for Cervical Cancer
Yahoo
11/23 10:41
Regeneron's Libtayo approved in EU for expanded use in cervical cancer
SA Breaking News
11/22 08:31
Regeneron Pharmaceuticals Obtains European Commission's Approval for Libtayo as Monotherapy in Cervical Cancer
MT Newswires
11/22 07:26
Libtayo® (cemiplimab) Approved by the European Commission as the First Immunotherapy in Second Line Recurrent or Metastatic Cervical Cancer Irrespective of PD-L1 Expression Level or Tumor Histology
PR Newswire
11/22 07:00
There's Reason For Concern Over Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Price
Yahoo
11/22 06:02
CytomX (CTMX) Stock Surges on Oncology Deal With Regeneron
Yahoo
11/18 13:18
Regeneron Pharmaceuticals (NASDAQ:REGN) shareholders have earned a 28% CAGR over the last three years
Yahoo
11/18 06:00
Sector Update: Healthcare Stocks Close Slightly Lower
MT Newswires
11/17 16:07
CytomX Shares Jump After Cancer Therapy Pact With Pharma Major Regeneron
Yahoo
11/17 11:14
Peninsula biotech moves from layoffs to cancer-fighting deal with potential $2B payoff
Yahoo
11/17 11:09
Fed Concerns Burden Markets as Investors Scrutinize Earnings Reports, Jobs, Housing Data
MT Newswires
11/17 09:31
CytomX, Regeneron to Collaborate on Cancer Therapies
MT Newswires
11/17 09:20
Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
Yahoo
11/17 07:00
CytomX and Regeneron Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
Yahoo
11/17 07:00
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
11/16 16:10
Top Russell 1000 Stocks
Yahoo
11/16 11:20
4D Molecular says its wet AMD therapy cuts Eylea burden
SA Breaking News
11/14 15:15
Bayer (BAYRY) Eylea Label Extension Gets CHMP Positive Opinion
Yahoo
11/14 10:10
Sanofi (SNY), Regeneron Dupixent Gets CHMP Nod for Skin Disease
Yahoo
11/14 07:43
U.S. COVID health emergency to stay in place
SA Breaking News
11/12 20:59
2 Top Biotech Stocks to Buy in November
Yahoo
11/12 10:15
Subdued Growth No Barrier To Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Price
Yahoo
11/12 09:00
--Guggenheim Lowers Price Target on Regeneron Pharmaceuticals to $915 From $925, Maintains Buy Rating
MT Newswires
11/11 09:23
Regeneron, Sanofi Say European Medicines Agency Committee Recommends Approval of Dupixent to Treat Prurigo Nodularis
MT Newswires
11/11 07:40
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Prurigo Nodularis
Yahoo
11/11 06:59
Apellis, IVERIC bio cut to Hold at Jefferies; says Street overestimates GA market
SA Breaking News
11/10 13:36
Regeneron Pharmaceuticals' Libtayo Combination Therapy Gets FDA Approval to Treat Non-small Cell Lung Cancer Subtype
MT Newswires
11/09 13:38
Regeneron pares gains after PTAB rules against Eylea patent
SA Breaking News
11/09 12:43
Biotech Stock Roundup: REGN, AMGN, MRNA's Q3 Earnings, VERV Down on Update
Yahoo
11/09 12:35
Regeneron (REGN) Gets FDA Nod for Libtayo's Label Expansion
Yahoo
11/09 10:43
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
11/09 07:19
Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC)
PR Newswire
11/08 16:41
Regeneron Pharmaceuticals Third Quarter 2022 Earnings: Beats Expectations
Yahoo
11/08 07:42
--UBS Adjusts Regeneron Pharmaceuticals Price Target to $862 From $823, Maintains Buy Rating
MT Newswires
11/07 09:48
Subdued Growth No Barrier To Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Price
Yahoo
11/06 08:00
Aflibercept 8 mg Late-breaking Data Presented at Retina Society in Diabetic Macular Edema and Wet Age-related Macular Degeneration
PR Newswire
11/04 19:30
10 Latest Earnings That Surprised Wall Street
Yahoo
11/04 18:03
Regeneron accelerates research spending as drug pipeline grows
Yahoo
11/04 15:05
Market Chatter: Amgen Gets Supreme Court Nod to Hear Appeal on Cholesterol Drug Patents
MT Newswires
11/04 14:55
7 Cash-Rich Stocks to Buy for Peace of Mind
Yahoo
11/04 14:22
U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents
Yahoo
11/04 14:09
UPDATE 3-U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents
Yahoo
11/04 14:08
RPT-U.S. Supreme Court to hear Amgen bid to revive Repatha patents
Yahoo
11/04 13:40
U.S. Supreme Court to hear Amgen bid to revive Repatha patents
Yahoo
11/04 13:32
Intellia's (NTLA) Q3 Loss Wider Than Expected, Revenues Up Y/Y
Yahoo
11/04 12:18
--SVB Leerink Adjusts Price Target on Regeneron Pharmaceuticals to $770 From $756, Maintains Market Perform Rating
MT Newswires
11/04 12:13
--Piper Sandler Adjusts Regeneron Pharmaceuticals' Price Target to $765 From $775, Keeps Overweight Rating
MT Newswires
11/04 10:38
--RBC Lowers Regeneron Pharmaceuticals' Price Target to $700 From $702, Keeps Sector Perform Rating
MT Newswires
11/04 09:24
Research Alert: CFRA Keeps Hold Opinion On Shares Of Regeneron Pharmaceuticals
MT Newswires
11/04 00:30
Regeneron Sinks Despite Massive Earnings Beat On A Notable Blockbuster Miss
Yahoo
11/03 17:02
Regeneron Announces Investor Conference Presentations
PR Newswire
11/03 16:05
Stock Market Extends Losses Despite Easing Labor Costs; Qualcomm, Roku At New Lows
Yahoo
11/03 12:03
Regeneron (REGN) Q3 Earnings & Sales Beat on Eylea, Dupixent
Yahoo
11/03 11:43
Regeneron Presents New Data at ASH from Advancing Hematology Pipeline across Multiple Blood Cancers and Disorders
Yahoo
11/03 09:00
Regeneron (REGN) Surpasses Q3 Earnings and Revenue Estimates
Yahoo
11/03 08:05
Regeneron Pharmaceuticals Posts Lower Q3 Non-GAAP Earnings, Revenue
MT Newswires
11/03 06:56
Regeneron Pharmaceuticals Q3 tops earnings and revenue marks
Yahoo
11/03 06:51
-- Earnings Flash (REGN) REGENERON PHARMACEUTICALS Posts Q3 Revenue $2.94B, vs. Street Est of $2.87B
MT Newswires
11/03 06:40
-- Earnings Flash (REGN) REGENERON PHARMACEUTICALS Posts Q3 EPS $11.14, vs. Street Est of $9.64
MT Newswires
11/03 06:40
Regeneron Reports Third Quarter 2022 Financial and Operating Results
Yahoo
11/03 06:30
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
11/02 16:51
AbCellera Says Program With Regeneron in Collaboration Project Advances into Preclinical Development
MT Newswires
11/02 13:33
Drug, Biotech Stocks' Q3 Earnings on Nov 3: AMGN, REGN & More
Yahoo
11/02 09:25
Are Investors Undervaluing Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) By 29%?
Yahoo
11/02 09:00
--EF Hutton Starts Regeneron Pharmaceuticals at Buy With $851 Price Target
MT Newswires
11/01 10:44
Regeneron (REGN) Q3 Earnings Coming Up: What's in the Cards?
Yahoo
10/31 11:49
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Yahoo
10/29 09:00
Sanofi (SNY) Q3 Earnings Beat, Dupixent, Flu Jabs Push Sales
Yahoo
10/28 12:51
Inmazeb™ (atoltivimab, maftivimab, and odesivimab-ebgn) Wins Prestigious 2022 Prix Galien USA Best Biotechnology Product Award
PR Newswire
10/28 08:00
Sanofi Q3 sales boosted by Dupixent, Vaccines business; raises FY22 outlook again
SA Breaking News
10/28 05:09
UPDATE 2-Sanofi sees faster profit growth on Dupixent, flu vaccine demand
Yahoo
10/28 02:12
Is Regeneron Pharmaceuticals (REGN) an Attractive Long-Term Stock?
Yahoo
10/27 13:01
Why Regeneron (REGN) Could Beat Earnings Estimates Again
Yahoo
10/27 12:10
Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Yahoo
10/27 10:02
Roche Vabysmo matches Eylea in 2 phase 3 trials for vision disorder
SA Breaking News
10/27 05:19
GSK to abandon regulatory filings for arthritis drug as phase 3 trial fails
SA Breaking News
10/27 04:48
--Raymond Downgrades Regeneron Pharmaceuticals to Underperform From Market Perform
MT Newswires
10/26 06:44
Regeneron (REGN) Gains But Lags Market: What You Should Know
Yahoo
10/25 18:15
Possible bearish signals as Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders disposed of US$16m worth of stock
Yahoo
10/25 09:00
Is it a Good Decision to Add Regeneron Pharmaceuticals (REGN) to Your Portfolio?
Yahoo
10/23 19:28
Talks begin with pharma, health insurers over negotiating drug prices for Medicare
SA Breaking News
10/21 13:56
--UBS Adjusts Regeneron Pharmaceuticals' Price Target to $823 From $770, Maintains Buy Rating
MT Newswires
10/21 10:01
Are Strong Financial Prospects The Force That Is Driving The Momentum In Regeneron Pharmaceuticals, Inc.'s NASDAQ:REGN) Stock?
Yahoo
10/21 09:00
Regeneron Pharmaceuticals Secures 6 Months of US Pediatric Exclusivity for the EYLEA Injection
MT Newswires
10/21 07:44
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA® (aflibercept) Injection
PR Newswire
10/21 07:00
--Cowen Increases Price Target on Regeneron Pharmaceuticals to $750 From $655, Maintains Market Perform Rating
MT Newswires
10/20 11:31
Chipotle among new additions to Oppenheimer's Trifecta pick list
SA Breaking News
10/20 07:15
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
10/18 16:11
Decibel Therapeutics hears it may be a takeout target after Lilly acquisition of Akouos
SA Breaking News
10/18 11:30
2 Biotech Stocks You Can Buy and Hold for the Next Decade
Yahoo
10/18 09:53
Regeneron (REGN) Stock Sinks As Market Gains: What You Should Know
Yahoo
10/17 18:15
Biotech Investors Need Patience (And a Strong Stomach)
Yahoo
10/17 14:22
Regeneron (REGN) Drug Gets Positive CHMP View for Cervical Cancer
Yahoo
10/17 13:36
Evercore ISI Downgrades Regeneron Pharmaceuticals to In Line from Outperform, Keeps $760 Price Target
MT Newswires
10/17 13:11
Morgan Stanely says large cap healthcare remains attractive amid macro concerns
SA Breaking News
10/17 10:34
An Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 37% Undervalued
Yahoo
10/17 10:00
Regeneron Pharmaceuticals, Immune-Onc Therapeutics Sign Clinical Supply Agreement for Solid Tumors Combined Therapy
MT Newswires
10/17 09:32
Decibel Therapeutics Says FDA Grants Clearance to Test DB-OTO to Provide Hearing to Patients With Otoferlin-Related Loss
MT Newswires
10/17 07:38
EMA committee recommends expanded approval of Regeneron's Libtayo for cervical cancer
SA Breaking News
10/14 09:07
Regeneron Pharmaceuticals Receives Positive CHMP Opinion for Libtayo to Treat Cervical Cancer
MT Newswires
10/14 07:27
Libtayo® (cemiplimab) Receives Positive CHMP Opinion Recommending Approval to Treat Advanced Cervical Cancer
PR Newswire
10/14 07:04
Regeneron's (REGN) Eylea sBLA Gets FDA's Priority Review
Yahoo
10/13 12:56
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Yahoo
10/13 10:00
3 Red-Hot Stocks That Could Continue to Beat the Market
Yahoo
10/13 06:30
Regeneron, Bayer Eylea gets FDA priority review for eye disorder in infants
SA Breaking News
10/12 08:53
Regeneron Says US FDA Grants Priority Review to Eylea Injection for Infants With Retinopathy of Prematurity
MT Newswires
10/12 07:29
EYLEA® (aflibercept) Injection sBLA for Treatment of Retinopathy of Prematurity (ROP) Accepted for FDA Priority Review
PR Newswire
10/12 07:00
Sanofi - Regeneron Tout Additional Positive Data From Flagship Dupixent Product
Yahoo
10/11 07:43
Regeneron, Sanofi Say Eosinophilic Esophagitis Treatment Achieved Disease Remission in Children in Phase 3 Trial
MT Newswires
10/11 04:12
Dupixent® (dupilumab) Late-Breaking Phase 3 Data Presented at UEG Week 2022 Showed Significant Histological Remission of Eosinophilic Esophagitis (EoE) in Children 1 to 11 Years Old
PR Newswire
10/11 00:59
GOP senators introduce bill to undo Medicare prescription drug negotiation
SA Breaking News
10/10 14:09
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Recent Stock Performance Tethered To Its Strong Fundamentals?
Yahoo
10/09 09:01
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
10/07 16:06
10 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
Yahoo
10/07 13:57
--RBC Raises Price Target on Regeneron Pharmaceuticals to $702 From $686, Maintains Sector Perform Rating
MT Newswires
10/06 07:41
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
10/05 16:17
Regeneron Pharmaceuticals' (NASDAQ:REGN) three-year earnings growth trails the 37% YoY shareholder returns
Yahoo
10/05 09:01
Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022
PR Newswire
10/04 16:00
REGN vs. RGEN: Which Stock Is the Better Value Option?
Yahoo
10/04 11:40
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Yahoo
10/04 10:23
Regeneron (REGN) Recently Broke Out Above the 20-Day Moving Average
Yahoo
10/04 09:35
Will Loss of REGEN-COV Sales Hurt Regeneron (REGN) in 2022?
Yahoo
10/04 09:15
Sanofi (SNY) Relies on Dupixent and Vaccines to Drive Growth
Yahoo
10/04 09:10
If You Invested $1000 in Regeneron 10 Years Ago, This Is How Much You'd Have Now
Yahoo
10/04 08:30
US Stocks Rally After ISM Manufacturing Data; Crude Oil Jumps
MT Newswires
10/03 17:16
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
10/03 16:13
AstraZeneca COVID-19 antibodies unlikely to protect against new Omicron subvariant
SA Breaking News
10/03 15:23
US Stocks Advance Midday After ISM Manufacturing Data; Crude Oil Advances
MT Newswires
10/03 13:22
Goldman Sachs Raises Regeneron Pharmaceuticals Price Target to $970 From $796, Maintains Buy Rating
MT Newswires
10/03 11:22
Regeneron Elects Dr. Craig B. Thompson to Board of Directors
Yahoo
10/03 07:00
Svante Pääbo gets Nobel Prize for Medicine for discoveries on genome, human evolution
SA Breaking News
10/03 06:14
COVID stocks lag U.S. biopharma in Q3; Alzheimer’s theme regains focus
SA Breaking News
10/02 12:00
Possible bearish signals as Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders disposed of US$16m worth of stock
Yahoo
10/01 10:00
Aflibercept 8 mg Positive Pivotal Results in Diabetic Macular Edema and Wet Age-Related Macular Degeneration Presented at AAO
Yahoo
09/30 17:04
Illumina Aims to Push Genetics Beyond the Lab With $200 Genome
Yahoo
09/29 14:11
Biotech Stock Roundup: BIIB's AD Drug Data & REGN, IONS, VRTX's Updates
Yahoo
09/29 12:12
Sanofi's (SNY) Dupixent Gets FDA Nod for Prurigo Nodularis
Yahoo
09/29 11:09
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
Yahoo
09/29 09:54
Dow Jones Futures Fall As Treasury Yields Rebound; Eli Lilly Leads 7 Bullish Stocks
Yahoo
09/29 08:12
Sanofi, Regeneron win FDA label expansion for Dupixent in chronic, skin condition
SA Breaking News
09/29 06:51
Regeneron Pharmaceuticals' Dupixent Receives FDA Approval for Chronic Skin Disease
MT Newswires
09/29 04:12
Dupixent® (dupilumab) Approved by FDA as the First and Only Treatment Indicated for Prurigo Nodularis
PR Newswire
09/28 17:44
Regeneron Stock Is Attempting an Upside Breakout
Yahoo
09/28 14:39
Insiders who sold Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) earlier year may find some solace in the 4.1% drop
Yahoo
09/27 09:00
10 Best ETFs to Diversify Your Portfolio and Avoid Risks
Yahoo
09/23 13:37
Possible bearish signals as Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders disposed of US$16m worth of stock
Yahoo
09/23 08:01
Decibel Therapeutics Files Investigational New Drug Application With US FDA for Product Candidate DB-OTO
MT Newswires
09/20 07:34
Are Strong Financial Prospects The Force That Is Driving The Momentum In Regeneron Pharmaceuticals, Inc.'s NASDAQ:REGN) Stock?
Yahoo
09/19 08:03
Intellia Investors Are Dumping Stock on News of Crispr Gene-Editing Success
Yahoo
09/16 16:37
Regeneron (REGN)/ Alnylam Report Promising Data from NASH Study
Yahoo
09/16 11:29
Intellia Therapeutics, Regeneron Say Genome Editing Therapy Reduced Protein Concentration in Phase 1 Trial
MT Newswires
09/16 09:42
Intellia Therapeutics Posts Back To Back Positive Data From Gene Editing Therapies
Yahoo
09/16 09:26
Sector Update: Health Care Stocks Mixed Premarket Friday
MT Newswires
09/16 09:17
Intellia Therapeutics, Regeneron Therapeutics Deliver Positive Early-Stage Data on ATTR Amyloidosis Treatment
MT Newswires
09/16 08:55
Intellia's stock is up 6% on data from an early-stage trial for its Crispr therapy
Yahoo
09/16 08:38
Canaccord Genuity Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $700, Reiterates Buy Rating
MT Newswires
09/16 08:30
Intellia and Regeneron Announce Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis
Yahoo
09/16 07:15
Regeneron Pharmaceuticals, Sanofi Say Atopic Dermatitis Drug Improved Skin Clearance in Children in Phase 3 Trial
MT Newswires
09/16 04:10
Positive Dupixent® (dupilumab) Phase 3 Data in Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis Published in The Lancet
PR Newswire
09/15 18:38
Alnylam/Regeneron-Backed NASH Candidate Shows Encouraging Safety Profile In Healthy Volunteers
Yahoo
09/15 09:41
Alnylam, Regeneron Say Safety Data From Phase 1 Trial Support Continued Liver Disease Drug Development
MT Newswires
09/15 07:50
Regeneron and Alnylam Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers
PR Newswire
09/15 07:00
Biotech Stock Roundup: BMY Surges on Drug Approval, REGN Up on Update & More
Yahoo
09/14 16:35
Regeneron Pharmaceuticals (NASDAQ:REGN) stock performs better than its underlying earnings growth over last three years
Yahoo
09/14 13:47
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
09/13 16:09
Piper Sandler Raises Price Target on Regeneron Pharmaceuticals to $775 From $692, Maintains Overweight Rating
MT Newswires
09/13 07:29
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
09/12 16:38
Guggenheim Adjusts Regeneron Pharmaceuticals Price Target to $925 From $740, Maintains Buy Rating
MT Newswires
09/12 11:36
Wells Fargo Adjusts Regeneron Pharmaceuticals' Price Target to $800 from $735, Maintains Overweight Rating
MT Newswires
09/12 09:57
Thinking about trading options or stock in Tesla, Bill.com, Twitter, Chevron, or Regeneron Pharmaceuticals?
PR Newswire
09/12 09:31
Regeneron's Bispecific Antibodies Show Encouraging Anti Tumor Activity
Yahoo
09/12 06:07
Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous Squamous Cell Carcinoma Presented at ESMO and Published in NEJM
PR Newswire
09/12 04:30
Regeneron Pharmaceuticals Says Combination Treatment Showed Higher Than 60% Response Rates in Skin Cancer Patients
MT Newswires
09/12 03:46
Fianlimab (LAG-3 Inhibitor) Combined with Libtayo® (cemiplimab) Demonstrates Greater than 60% Response Rates in Two Independent Cohorts of Patients with Advanced Melanoma Naïve to PD-1 or PD-L1 Inhibitors
PR Newswire
09/12 02:30
Novel Regeneron Bispecific Antibodies Show Encouraging Anti-tumor Activity in Two Advanced Solid Tumors
PR Newswire
09/10 02:30
The 3 Best Healthcare Stocks to Buy Now
Yahoo
09/09 18:00
Research Alert: CFRA Keeps Hold Opinion On Shares Of Regeneron Pharmaceuticals
MT Newswires
09/09 16:55
Regeneron's Eylea Win Leaves an Elephant in the Room
Yahoo
09/09 15:58
Regeneron Gets Praised by Wall Street. High-Dose Eylea Data Look ‘Strong.’
Yahoo
09/09 15:56
Regeneron Pharmaceuticals Shares Rise After Analyst Upgrades, Price Target Raises
MT Newswires
09/09 13:35
'Highly Compelling' Eye Drug Data Has Wall Street Stampeding To Buy This 'Large Cap Growth Story.' Even After $15B In Market Cap Was Added
Yahoo
09/09 11:14
Regeneron Announces Investor Call and Webcast at ESMO 2022
PR Newswire
09/09 10:00
SVB Securities Adjusts Price Target on Regeneron Pharmaceuticals to $756 From $630, Maintains Market Perform Rating
MT Newswires
09/09 09:51
Thinking about trading options or stock in Docusign, Coinbase Global, NVIDIA, Regeneron Pharmaceuticals, or Tesla?
PR Newswire
09/09 09:43
Barclays Adjusts Regeneron Pharmaceuticals' Price Target to $815 From $735, Maintains Overweight Rating
MT Newswires
09/09 09:36
Company News for Sep 9, 2022
Yahoo
09/09 09:31
Morgan Stanley Upgrades Regeneron Pharmaceuticals to Overweight From Equalweight, Boosts Price Target to $851 From $625, Cites Removal of Eylea Tail Risk
MT Newswires
09/09 08:45
Regeneron (REGN) Up on Higher Dose Eye Drug Studies Success
Yahoo
09/09 08:36
DocuSign, Digital World, Zscaler, Crypto Stocks, and More Stock Market Movers Friday
Yahoo
09/09 07:44
Jefferies Upgrades Regeneron Pharmaceuticals to Hold From Underperform, Raises Price Target to $675 From $536
MT Newswires
09/09 06:51
DocuSign, Zscaler, T-Mobile US Rise Premarket; Smith & Wesson Falls
Yahoo
09/09 03:48
US Stocks Advance Thursday as Fed's Powell Reiterates Commitment to Fighting Inflation
MT Newswires
09/08 17:17
US Stocks Advance Thursday Despite Fed Chief Powell's Comments Indicating More Rate Hikes
MT Newswires
09/08 16:16
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
09/08 16:10
Regeneron Stock Soars On Pair Of Successful Trials
Yahoo
09/08 16:09
Market indices clinch gains at the close, meme stocks jump
Yahoo
09/08 16:07
Sector Update: Health Care Stocks Ending Near Intraday Highs
MT Newswires
09/08 16:02
Regeneron stock surges on positive results in eye disease drug trial
Yahoo
09/08 15:57
Regeneron Stock Surges on Promising Eye Disease Drug Trial Results
Yahoo
09/08 14:50
Regeneron Soars But This Biotech ETF Is the Better Way to Get Exposure
Yahoo
09/08 14:33
Why Regeneron Pharmaceuticals Stock Is Crushing It Today
Yahoo
09/08 14:32
Regeneron-Sanofi Eczema Drug Shows Improvements In Itchy Inflammatory Skin Disease
Yahoo
09/08 13:53
Top Midday Gainers
MT Newswires
09/08 13:36
Midday Report: US Stocks Give up Gains While Treasury Yields Rise as Powell Reinforces Resolve to Continue Fighting Inflation
MT Newswires
09/08 13:11
Equities Surrender Gains as Powell Reinforces Resolve to Continue Fighting Inflation
MT Newswires
09/08 13:09
SpringWorks (SWTX), GSK Expand Deal to Treat Multiple Myeloma
Yahoo
09/08 12:54
Evercore ISI Adjusts Regeneron Pharmaceuticals' Price Target to $660 from $635, Maintains Outperform Rating
MT Newswires
09/08 12:44
Truist Securities Adjusts Regeneron Pharmaceuticals' Price Target to $790 from $718, Maintains Buy Rating
MT Newswires
09/08 12:43
Dupixent® (dupilumab) Late-breaking Phase 3 Data at the EADV 2022 Congress Showed Significant Improvements in Signs and Symptoms of Prurigo Nodularis
Yahoo
09/08 11:29
UPDATE 1-Bayer, Regeneron's eye drug shown to work at higher dose, longer intervals
Yahoo
09/08 10:32
Stocks fluctuate, Regeneron stock surges, oil above $83 a barrel
Yahoo
09/08 10:19
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
Yahoo
09/08 10:11
Regeneron Pharmaceuticals Says Aflibercept 8 mg for Diabetic Macular Edema and wAMD Met Primary Endpoints in Trials
MT Newswires
09/08 09:38
Regeneron says Eylea met the primary endpoints in two trials
Yahoo
09/08 09:23
Bayer, Regeneron's eye drug shown to work at higher dose, longer intervals
Yahoo
09/08 09:08
Aflibercept 8 mg Meets Primary Endpoints in Two Global Pivotal Trials for DME and wAMD, with a Vast Majority of Patients Maintained on 12- and 16-week Dosing Intervals
PR Newswire
09/08 09:00
Sanofi-Regeneron's Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma In Kids
Yahoo
09/06 07:10
Late-Breaking Dupixent® (dupilumab) Data at ERS 2022 Show Consistent Efficacy and Safety Profile for Up to Two Years in Children Aged 6 to 11 Years with Moderate-to-severe Asthma
PR Newswire
09/05 07:29
ESMO Presentations of Libtayo® (cemiplimab), Fianlimab and Novel Bispecific Antibodies Showcase Expanding Potential of Regeneron's Oncology Pipeline in Multiple Cancers
PR Newswire
09/04 18:05
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
09/02 16:12
RBC Capital Cuts Price Target on Regeneron Pharmaceuticals to $628 From $647, Keeps Sector Perform Rating
MT Newswires
09/02 08:45
Alnylam Pharmaceuticals Reports Positive Results From Phase 2 Study of Cemdisiran to Treat IgA Nephropathy
MT Newswires
08/29 09:19
Regeneron Announces Investor Conference Presentations
PR Newswire
08/25 16:05
CDC seeks reforms to correct COVID missteps
SA Breaking News
08/17 13:10
Unity extends gains on data for lead asset in diabetic macular edema
SA Breaking News
08/15 06:51
Analysts rule out major industry impact from drug pricing negotiations
SA Breaking News
08/14 13:48
AbbVie, Roche, Regeneron could significantly benefit as AMD market expected to soar
SA Breaking News
08/13 16:00
Unity Biotech jumps 93% after data for lead asset in diabetic macular edema
SA Breaking News
08/12 07:39
CDC eases COVID guidance for unvaccinated people
SA Breaking News
08/11 15:26
Research Alert: CFRA Keeps Hold Opinion On Shares Of Regeneron Pharmaceuticals
MT Newswires
08/10 18:50
Insider Sell: Regeneron Pharmaceuticals
MT Newswires
08/09 09:12
$35 per month capped insulin for private insurance kept out of Inflation Reduction Act
SA Breaking News
08/07 18:19
--Goldman Sachs Increases Regeneron Pharmaceuticals' Price Target to $796 From $790, Maintains Buy Rating
MT Newswires
08/04 11:18
--Morgan Stanley Raises Regeneron Pharmaceuticals' Price Target to $625 From $619, Maintains Equalweight Rating
MT Newswires
08/04 11:08